title: [Early esophageal cancer: pro-endoscopic resection].
abstract: In several publications including more than 1,000 endoscopically treated patients it could be demonstrated that endoscopic treatment of early esophageal cancer is effective and safe. A combination of endoscopic resection (ER) of early Barrett's neoplasia followed by ablation of the remaining non-dysplastic Barrett's mucosa was able to significantly reduce the rate of recurrence and metachronous neoplasia. Long-term complete remission rates of more than 95% can be achieved. Compared to esophagectomy, endoscopic treatment has only a very low complication rate and almost no mortality. Therefore, ER is the treatment of choice and recommended by several international guidelines. Esophageal resection only plays a minor role in patients with early esophageal cancer.
authors.affiliation: Innere Medizin 2, HSK Wiesbaden, Deutschland. oliver.pech@hsk-wiesbaden.de
authors.forename: O
authors.initials: O
authors.lastname: Pech
authors.forename: C
authors.initials: C
authors.lastname: Ell
mesh_terms: D001471:Barrett Esophagus / Q000473:pathology / Q000601:surgery*; D018572:Disease-Free Survival; D004938:Esophageal Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D004945:Esophagoscopy; D004947:Esophagus / Q000473:pathology / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000517:prevention & control; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic; D011230:Precancerous Conditions / Q000401:mortality / Q000473:pathology / Q000601:surgery*